NASDAQ NMS - GLOBAL MARKET · APGE
+0.03% · +$0.0400 · Vol 1.1M
Market closed · last close 4:00 PM ET · price as of 16:55:42 ET
Apogee Therapeutics Inc

Apogee Therapeutics Inc

Biotechnology
$134.79
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
APGE
Apogee Therapeutics Inc
Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

74/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is APGE moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading APGE catalysts
About Apogee Therapeutics Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2023
Employees
261
Country
US

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$134.75
Day high
$134.83
Day low
$134.71
Previous close
$134.75
52W high
$134.84
-0.04% from high
52W low
$36.37
100% of range
Market cap
$10.2B
EPS
$-4.4400
Beta
0.34
Shares out
75.7M
Volume
1.1M
0.96× rel vol
Avg volume
1.2M
VWAP
$134.77
Price history computed in-house
1W
+0.16%
1M
+0.38%
3M
+73.36%
1Y
+264.89%
YTD
+78.58%
SMA 50 $129.31 · above
SMA 200 $89.30 · above
52W position 100%

APGE overview

Veridion Score
74
Registered · 2026-08-24
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around APGE.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading APGE Form 4 filings
Public disclosures

Congress activity in APGE

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for APGE in the cached public ledger.

Federal contracts

APGE contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for APGE in this window.
Lobbying spend

APGE lobbying filings, year to date.

Registered lobbying filings matched to Apogee Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for APGE in this window.
Loading news for APGE
Analyst ratings
Sovereign unlock shows live analyst consensus for APGE.
Options
Sovereign unlock shows live options positioning for APGE.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.